奥马佐单抗
哮喘
医学
儿科
重症监护医学
内科学
免疫球蛋白E
免疫学
抗体
作者
Aykut Çilli,Fatih Üzer,Gamze Ozbey
出处
期刊:Journal of Asthma
[Taylor & Francis]
日期:2024-05-28
卷期号:61 (11): 1469-1476
被引量:5
标识
DOI:10.1080/02770903.2024.2361777
摘要
Omalizumab has the potential to induce disease remission in a significant proportion of people with severe asthma, and this is maintained and improved over time.
科研通智能强力驱动
Strongly Powered by AbleSci AI